Skip to content

To evaluate the safety and efficacy of laparoscopic hepatectomy assisted by laparoscopic endoscopic surgery system

To evaluate the safety and efficacy of laparoscopic hepatectomy assisted by laparoscopic endoscopic surgery system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080197
Enrollment
Unknown
Registered
2024-01-23
Start date
2024-02-04
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) 18 years old = age = 75 years old, regardless of gender; (2) patients who required hepatectomy according to the investigator's judgment; (3) be able to cooperate and complete follow-up and related examinations; (4) voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Severe coagulation dysfunction, obvious bleeding tendency (platelets < 100x10 9 PCS /L); (3) History of major abdominal surgery, intraperitoneal adhesion difficult to separate exposed lesions; (4) There are serious complications that cannot tolerate pneumoperitoneum, surgery or anesthesia; (5) Combined with surgical site or systemic infection, severe inflammatory reaction; (6) The lesion is adjacent to or directly invading the large blood vessels; (7) The important structure of the hilar is invaded, or the need to expand the retroperitoneal lymph node dissection; (8) Patients with liver cancer: CNLC stage Ib and above; (9) Emergency surgery; (10) Spontaneous rupture and hemorrhage of primary liver cancer; (11) Participants in other investigational drug or device clinical trials have not been completed; (12) Patients considered unsuitable for participation in this project by the investigator.

Design outcomes

Primary

MeasureTime frame
No conversion rate;Overall incidence of surgical complications;

Secondary

MeasureTime frame
Complication incidence rate intraoperative bleeding volume and intraoperative blood transfusion volume;operative time;Postoperative pain score;Equipment defect incidence rate;postoperative hospitalization time;The incidence of device related or potentially related complications;Drainage volume within 24 hours after surgery;Laboratory Examination;AE/SAE;

Countries

China

Contacts

Public ContactXiaodong Li

Peking University First Hospital

tianxiaodong@pkufh.com+86 139 1163 6280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026